Tao, Pan,
Galiullin, D,
Chen, X.L.,
Zhang, W.H.,
Yang, K,
Liu, K,
Zhao, L.Y.,
Chen, X.Z.,
Hu, J.K. (2021) . The performance of the model was assessed with its discrimination, calibration, and
clinical usefulness. A total
Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) with
clinical and pathological parameters of tumor progression including lymphatic and hematogenous metastasis
YANG, L,
LI, Y,
GONG, R,
GAO, M.Q.,
FENG, C,
LIU, T.Y.,
SUN, Y,
JIN, M.Y.,
WANG, D.W.,
YUAN, Y,
YAN, G.G.,
HE, M.Y.,
IDIYATULLINA, E.T.,
MA, W.Y.,
HAN, Z.B.,
ZHANG, L,
HUANG, Q.,
DING, F.Z.,
CAI, B.Z.,
CAI, B.Z.,
YANG, F. (2019) vertigo (BPPV). However, the frequency and
clinical characteristics of BPPV in MD are unclear. The aim
Motloch, L.J.,
Larbig, R.,
Darabi, T.,
Reda, S.,
Motloch, K.A.,
Wernly, B.,
Lichtenauer, M.,
Gebing, T.,
Schwaiger, A.,
Zagidullin, N.,
Wolny, M.,
Hoppe, U.C. (2017) clinical symptoms. Hyperpolarization-activated cyclic nucleotide channel 4 (HCN4) underlies the pacemaker
Yunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) recommendations. Altogether, 369 patients completed the full course of chemotherapy.
Clinical characteristics
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Holz, Frank G.,
Panda-Jonas, Songhomitra,
Gilemzianova, Leisan I.,
Khakimov, Dinar A.,
Jonas, Jost B. (2023) in
clinical use in oncology, as a potential future therapeutic approach for axial elongation in adult eyes